Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- How to Handle Mycoplasma in Cell Culture?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Assess the Migratory and Invasive Capacity of Cells?
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- How to Isolate PBMCs from Whole Blood?
- CHO Cell Line Development
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Comparison of the MSCs from Different Sources
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- Tips For Cell Cryopreservation
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- T Cell Activation and Expansion
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Quantification of Cytokines
- IL-12 Family Cytokines and Their Immune Functions
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- Contamination of Cell Cultures & Treatment
- Cell Culture Medium
- What Are Myeloid Cell Markers?
- Cryopreservation of Cells Step by Step
- Cell Cryopreservation Techniques and Practices
- Human Primary Cells: Definition, Assay, Applications
- How to Eliminate Mycoplasma From Cell Cultures?
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Direct vs. Indirect Cell-Based ELISA
- What Is Cell Proliferation and How to Analyze It?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- How to Decide Between 2D and 3D Cell Cultures?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- What are PBMCs?
- How to Start Your Culture: Thawing Frozen Cells
- Techniques for Cell Separation
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Optimization Strategies of Cell-Based Assays
- Immunogenicity Testing: ELISA and MSD Assays
- 3D-Cell Model in Cell-Based Assay
- Types of Cell Therapy for Cancer
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Cell-Based High-Throughput Screening Techniques
- What Are CAR T Cells?
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Understanding Immunogenicity Assays: A Comprehensive Guide
- 3D-Cell Model in Cell-Based Assay
- Role of Cell-Based Assays in Drug Discovery and Development
- Immunogenicity Testing: ELISA and MSD Assays
- Optimization Strategies of Cell-Based Assays
- Adherent and Suspension Cell Culture
- Organoid Drug Screening
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- From Specimen to Slide: Core Methods in Histological Practice
- Modern Histological Techniques
- Overview of Cell Apoptosis Assays
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Cell Viability, Proliferation and Cytotoxicity Assays
-
Histology
- Multiple Animal Tissue Arrays
- Tips for Choosing the Right Protease Inhibitor
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Troubleshooting in Fluorescent Staining
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Guides for Live Cell Imaging Dyes
- Overview of the FFPE Cell Pellet Product Lines
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Cell Lysates: Composition, Properties, and Preparation
- Microscope Platforms
- Mitochondrial Staining
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Immunohistochemistry Controls
- Comparison of Membrane Stains vs. Cell Surface Stains
-
Exosome
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Apply Exosomes in Clinical?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- What's the Potential of PELN in Disease Treatment?
- Emerging Technologies and Methodologies for Exosome Research
- Summary of Approaches for Loading Cargo into Exosomes
- How to Perform Targeted Modification of Exosomes?
- How to Enhancement Exosome Production?
- How to characterize exosomes?
- How to Label Exosomes?
- Classification, Isolation Techniques and Characterization of Exosomes
- Exosome Quality Control: How to Do It?
- The Role of Exosomes in Cancer
- Techniques for Exosome Quantification
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- Unraveling Biogenesis and Composition of Exosomes
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Exosome Transfection for Altering Biomolecular Delivery
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- How Important are Lipids in Exosome Composition and Biogenesis?
- Exosome Antibodies
- Common Techniques for Exosome Nucleic Acid Extraction
-
ISH/FISH
- What Types of Multicolor FISH Probe Sets Are Available?
- What Is the Use of FISH in Solid Tumors?
- Mapping of Transgenes by FISH
- Reagents Used in FISH Experiments
- ISH probe labeling method
- Telomere Length Measurement Methods
- FISH Tips and Troubleshooting
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- Multiple Approaches to Karyotyping
- RNAscope ISH Technology
- CARD-FISH: Illuminating Microbial Diversity
- What are the Differences between FISH, aCGH, and NGS?
- Overview of Oligo-FISH Technology
- Differences Between DNA and RNA Probes
- Comparative Genomic Hybridization and Its Applications
- Small RNA Detection by ISH Methods
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Guidelines for the Design of FISH Probes
- How to Use FISH in Hematologic Neoplasms?
- Different Types of FISH Probes for Oncology Research
- In Situ Hybridization Probes
- Overview of Common FISH Techniques
- What are Single, Dual, and Multiplex ISH?
-
Toxicokinetics & Pharmacokinetics
- How to Improve Drug Plasma Stability?
- What Are Metabolism-Mediated Drug-Drug Interactions?
- Pharmacokinetics of Therapeutic Peptides
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- Experimental Methods for Identifying Drug-Drug Interactions
- Organ-on-a-Chip Systems for Drug Screening
- Key Considerations in Toxicokinetic
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Methods of Parallel Artificial Membrane Permeability Assays
- How to Conduct a Bioavailability Assessment?
- Overview of In Vitro Permeability Assays
- Traditional vs. Novel Drug Delivery Methods
- Predictive Modeling of Metabolic Drug Toxicity
- The Rise of In Vitro Testing in Drug Development
- What Are Compartment Models in Pharmacokinetics?
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- Key Factors Influencing Brain Distribution of Drugs
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Physical and Chemical Properties of Drugs and Calculations
- Unraveling the Role of hERG Channels in Drug Safety
-
Disease Models
- What Human Disease Models Are Available for Drug Development?
- Preclinical Models of Acute Liver Failure
- Overview of Cardiovascular Disease Models in Drug Discovery
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Why Use PDX Models for Cancer Research?
- Disease Models of Diabetes Mellitus
- Animal Models of Neurodegenerative Diseases
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter
Decalcification Protocol
GUIDELINE
- Decalcification is required for processing bone tissue in routine diagnostic practice. Control of this step is crucial because it may have important consequences for establishing the diagnosis.
- Agents commonly used for decalcification are acids of varying ionic strength or chelating agents. Acids that ionize and solubilize calcium ions include strong inorganic acids, such as hydrochloric or nitric acid, and weaker organic acids such as formic or phosphoric acid. Chelating agents such as ethylenediaminetetraacetic acid (EDTA) link to calcium ions and form an insoluble complex.
METHODS
Routine Decalcification
- Make 14% EDTA solution. Add 140 g free acid EDTA to 700 ml distilled H2O. On stir plate in the fume hood, add ammonium hydroxide 30 ml at a time until solution clears (about 90 ml total). Add H2O to almost 1 L. Check pH and adjust with ammonium hydroxide dropwise up to pH 7.2, then adjust final volume to 1 L.
- Place fixed / rinsed tissue in at least 15 volumes of 14% EDTA, and change daily or 5x / week (M-F) with mixing, this means at least 15 ml for a mouse tibia / femur. Placing tissue in a screw-top tube on its side, on a rocker works well. We tape tubes into a rack and place the whole thing on its side on the rocker.
- Time of decalcification varies with tissue size, species, etc. Mouse adult long bones and vertebrae need 10-14 days, and isolated calvaria needs 2-4 days.
- Rinse in H2O x 4. For paraffin embedding, place in 30%, 50%, and 70% ETOH for at least 30 min each prior to submitting to core lab; For frozen sections, blot tissue dry and freeze in OCT.
Hurry-Up Decalcification
- Reagent preparation. We need prepare 12.6 g aluminum chloride (hydrous), 8.5 ml 10 N hydrochloric acid, 5.4 ml 88% formic acid.
- Make final volume to 100 ml. Dilute 1 part of this stock solution with 4 parts of dH2O for LM histology (or immunohistochemistry) and 1:8 for tissues being processed for EM.
- Decalcification of an entire head of a 100 g rat takes only about 5 days in this solution at 1:4 dilution. It is truly amazing how quickly it works and how reasonable the tissues look afterwards.
- We usually do the decalcification at 4°C as with EDTA (with stirring, large fluid to tissue ratio). You should change this solution daily. Wash the tissues liberally after decalcification as with EDTA.
NOTES
- The fluid volume to tissue ratio is very critical for the decalcification process. It should be as large as practical, for example, no more than 10 or 15 hemi-jaws per liter of solution.
- You should change the solution every other day, pre chill the new batch to keep temperature at 4°C at all times.
- It is important to clean away as much muscle and soft tissues from the hemi-jaw bones, excess tissues act as a barrier to the decalcification process.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.